Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine A Blish

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
Pathogens & Immunity|September 17, 2016
Natural Killer Cell Diversity in Viral Infection: Why and How Much?Catherine A Blish
The Journal of Infectious Diseases|September 22, 2012
HIV-1 transmission goes retro (steps back)Catherine A Blish
The Journal of Infectious Diseases|August 21, 2018
Maintaining a Robust Pipeline of Future Physician-ScientistsCatherine A Blish
Cell Host & Microbe|May 29, 2020
The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19?Julia L McKechnie, Catherine A Blish
Nature Immunology|July 17, 2023
Defining the role of natural killer cells in COVID-19Madeline J Lee, Catherine A Blish
Frontiers in Immunology|June 20, 2015
Immunogenicity and Clinical Efficacy of Influenza Vaccination in PregnancyAlexander W Kay, Catherine A Blish
The Journal of Infectious Diseases|August 10, 2014
Delayed BCG vaccination--time to take a shotAlexander W Kay, Catherine A Blish
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|November 20, 2010
Hormonal contraception and HIV-1 transmissionCatherine A Blish, Jared M Baeten
Journal of Leukocyte Biology|January 20, 2018
Diversification of human NK cells: Lessons from deep profilingAaron J Wilk, Catherine A Blish
Immunity|June 12, 2024
Challenges and opportunities in long COVID researchRebecca E Hamlin, Catherine A Blish
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
Pathogens & Immunity|September 17, 2016
Natural Killer Cell Diversity in Viral Infection: Why and How Much?Catherine A Blish
The Journal of Infectious Diseases|September 22, 2012
HIV-1 transmission goes retro (steps back)Catherine A Blish
The Journal of Infectious Diseases|August 21, 2018
Maintaining a Robust Pipeline of Future Physician-ScientistsCatherine A Blish
Cell Host & Microbe|May 29, 2020
The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19?Julia L McKechnie, Catherine A Blish
Nature Immunology|July 17, 2023
Defining the role of natural killer cells in COVID-19Madeline J Lee, Catherine A Blish
Frontiers in Immunology|June 20, 2015
Immunogenicity and Clinical Efficacy of Influenza Vaccination in PregnancyAlexander W Kay, Catherine A Blish
The Journal of Infectious Diseases|August 10, 2014
Delayed BCG vaccination--time to take a shotAlexander W Kay, Catherine A Blish
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|November 20, 2010
Hormonal contraception and HIV-1 transmissionCatherine A Blish, Jared M Baeten
Journal of Leukocyte Biology|January 20, 2018
Diversification of human NK cells: Lessons from deep profilingAaron J Wilk, Catherine A Blish
Immunity|June 12, 2024
Challenges and opportunities in long COVID researchRebecca E Hamlin, Catherine A Blish
Pageof 15